Skip to main content
SpringerLink
Log in

Cardiovascular Implantable Electronic Device Infection

  • Chapter
  • First Online:
FDG-PET/CT and PET/MR in Cardiovascular Diseases

Abstract

Cardiac implantable electronic devices (CIED) and left ventricular assist devices (LVAD) are increasingly used worldwide with expanding indications. Among all CIED and LVAD complications, infection is associated with the greatest morbidity, mortality, and a substantial economic burden. The diagnosis of CIED and LVAD infections remains challenging because of the nonspecific clinical presentation and the limitation of conventional imaging (i.e., US and CT). CIED and LVAD infection treatment requires re-intervention with complete removal of some or all parts of the hardware and targeted antimicrobial therapy.

The European Society of Cardiology included 18F-flurodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) in its recent CIED infection guidelines. FDG PET/CT provides information when the diagnosis of CIED infection is uncertain and can detect extracardiac septic foci and infection portal of entry. Although FDG PET/CT value in improving the diagnostic of LVAD infection is not as well established, evidence of FDG PET/CT usefulness in LVAD infection diagnosis is increasing.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Mond HG, Proclemer A. The 11th world survey of cardiac pacing and implantable cardioverter-defibrillators: calendar year 2009: a world Society of Arrhythmia’s project. Pacing Clin Electrophysiol. 2011;34(8):1013–27.

    Article  PubMed  Google Scholar 

  2. Blomström-Lundqvist C, Traykov V, Erba PA, Burri H, Nielsen JC, Bongiorni MG, et al. European heart rhythm association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Europace. 2020;22(4):515–49.

    Article  PubMed  Google Scholar 

  3. Gitenay E, Molin F, Blais S, Tremblay V, Gervais P, Plourde B, et al. Cardiac implantable electronic device infection: detailed analysis of cost implications. Can J Cardiol. 2018;34(8):1026–32.

    Article  PubMed  Google Scholar 

  4. Nagpal A, Baddour LM, Sohail MR. Microbiology and pathogenesis of cardiovascular implantable electronic device infections. Circ Arrhythm Electrophysiol. 2012;5(2):433–41.

    Article  PubMed  Google Scholar 

  5. Krahn AD, Longtin Y, Philippon F, Birnie DH, Manlucu J, Angaran P, et al. Prevention of arrhythmia device infection trial: the PADIT trial. J Am Coll Cardiol. 2018;72(24):3098–109.

    Article  PubMed  Google Scholar 

  6. Patel R. Biofilms and antimicrobial resistance. Clin Orthop Relat Res. 2005;437:41–7.

    Article  Google Scholar 

  7. Bongiorni MG, Burri H, Deharo JC, Starck C, Kennergren C, Saghy L, et al. 2018 EHRA expert consensus statement on lead extraction: recommendations on definitions, endpoints, research trial design, and data collection requirements for clinical scientific studies and registries: endorsed by APHRS/HRS/LAHRS. Europace. 2018;20(7):1217.

    Article  PubMed  Google Scholar 

  8. Athan E, Chu VH, Tattevin P, Selton-Suty C, Jones P, Naber C, et al. Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices. JAMA. 2012;307(16):1727–35.

    Article  CAS  PubMed  Google Scholar 

  9. Rodriguez Y, Greenspon AJ, Sohail MR, Carrillo RG. Cardiac device-related endocarditis complicated by spinal abscess. Pacing Clin Electrophysiol. 2012;35(3):269–74.

    Article  PubMed  Google Scholar 

  10. Dundar C, Tigen K, Tanalp C, Izgi A, Karaahmet T, Cevik C, et al. The prevalence of echocardiographic accretions on the leads of patients with permanent pacemakers. J Am Soc Echocardiogr. 2011;24(7):803–7.

    Article  PubMed  Google Scholar 

  11. Rickard J, Tarakji K, Cheng A, Spragg D, Cantillon DJ, Martin DO, et al. Survival of patients with biventricular devices after device infection, extraction, and reimplantation. JACC Heart Fail. 2013;1(6):508–13.

    Article  PubMed  Google Scholar 

  12. Mochizuki T, Tsukamoto E, Kuge Y, Kanegae K, Zhao S, Hikosaka K, et al. FDG uptake and glucose transporter subtype expressions in experimental tumor and inflammation models. J Nucl Med. 2001;42(10):1551–5.

    CAS  PubMed  Google Scholar 

  13. Daneshmand MA, Rajagopal K, Lima B, Khorram N, Blue LJ, Lodge AJ, et al. Left ventricular assist device destination therapy versus extended criteria cardiac transplant. Ann Thorac Surg. 2010;89(4):1205–9; discussion 1210.

    Article  PubMed  Google Scholar 

  14. Kilic A, Acker MA, Atluri P. Dealing with surgical left ventricular assist device complications. J Thorac Dis. 2015;7(12):2158–64.

    PubMed  PubMed Central  Google Scholar 

  15. Hannan MM, Husain S, Mattner F, Danziger-Isakov L, Drew RJ, Corey GR, et al. Working formulation for the standardization of definitions of infections in patients using ventricular assist devices. J Heart Lung Transplant. 2011;30(4):375–84.

    Article  PubMed  Google Scholar 

  16. Nienaber JJC, Kusne S, Riaz T, Walker RC, Baddour LM, Wright AJ, et al. Clinical manifestations and management of left ventricular assist device-associated infections. Clin Infect Dis. 2013;57(10):1438–48.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Litzler P-Y, Manrique A, Etienne M, Salles A, Edet-Sanson A, Vera P, et al. Leukocyte SPECT/CT for detecting infection of left-ventricular-assist devices: preliminary results. J Nucl Med. 2010;51(7):1044–8.

    Article  PubMed  Google Scholar 

  18. Kim J, Feller ED, Chen W, Liang Y, Dilsizian V. FDG PET/CT for early detection and localization of left ventricular assist device infection: impact on patient management and outcome. JACC Cardiovasc Imaging. 2019;12(4):722–9.

    Article  CAS  PubMed  Google Scholar 

  19. de Vaugelade C, Mesguich C, Nubret K, Camou F, Greib C, Dournes G, et al. Infections in patients using ventricular-assist devices: comparison of the diagnostic performance of 18F-FDG PET/CT scan and leucocyte-labeled scintigraphy. J Nucl Cardiol. 2019;26(1):42–55.

    Article  PubMed  Google Scholar 

  20. Tam MC, Patel VN, Weinberg RL, Hulten EA, Aaronson KD, Pagani FD, et al. Diagnostic accuracy of FDG PET/CT in suspected LVAD infections: a case series, systematic review, and meta-analysis. JACC Cardiovasc Imaging. 2020;13(5):1191–202.

    Article  PubMed  Google Scholar 

  21. Ten Hove D, Treglia G, Slart RHJA, Damman K, Wouthuyzen-Bakker M, Postma DF, et al. The value of 18F-FDG PET/CT for the diagnosis of device-related infections in patients with a left ventricular assist device: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging. 2021;48(1):241–53.

    Article  PubMed  Google Scholar 

  22. Uslan DZ, Sohail MR, St Sauver JL, Friedman PA, Hayes DL, Stoner SM, et al. Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study. Arch Intern Med. 2007;167(7):669–75.

    Article  PubMed  Google Scholar 

  23. Knigina L, Kühn C, Kutschka I, Oswald H, Klein G, Haverich A, et al. Treatment of patients with recurrent or persistent infection of cardiac implantable electronic devices. Europace. 2010;12(9):1275–81.

    Article  PubMed  Google Scholar 

  24. Klug D, Lacroix D, Savoye C, Goullard L, Grandmougin D, Hennequin JL, et al. Systemic infection related to endocarditis on pacemaker leads: clinical presentation and management. Circulation. 1997;95(8):2098–107.

    Article  CAS  PubMed  Google Scholar 

  25. Leuck A-M. Left ventricular assist device driveline infections: recent advances and future goals. J Thorac Dis. 2015;7(12):2151–7.

    PubMed  PubMed Central  Google Scholar 

  26. Flachskampf FA, Wouters PF, Edvardsen T, Evangelista A, Habib G, Hoffman P, et al. Recommendations for transoesophageal echocardiography: EACVI update 2014. Eur Heart J Cardiovasc Imaging. 2014;15(4):353–65.

    Article  PubMed  Google Scholar 

  27. Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta J-P, Del Zotti F, et al. 2015 ESC guidelines for the management of infective endocarditis: the task force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36(44):3075–128.

    Article  PubMed  Google Scholar 

  28. Botelho-Nevers E, Thuny F, Casalta JP, Richet H, Gouriet F, Collart F, et al. Dramatic reduction in infective endocarditis-related mortality with a management-based approach. Arch Intern Med. 2009;169(14):1290–8.

    Article  PubMed  Google Scholar 

  29. Boersma LV, Barr CS, Burke MC, Leon AR, Theuns DA, Herre JM, et al. Performance of the subcutaneous implantable cardioverter-defibrillator in patients with a primary prevention indication with and without a reduced ejection fraction versus patients with a secondary prevention indication. Heart Rhythm. 2017;14(3):367–75.

    Article  PubMed  Google Scholar 

  30. Bannay A, Hoen B, Duval X, Obadia J-F, Selton-Suty C, Le Moing V, et al. The impact of valve surgery on short- and long-term mortality in left-sided infective endocarditis: do differences in methodological approaches explain previous conflicting results? Eur Heart J. 2011;32(16):2003–15.

    Article  PubMed  Google Scholar 

  31. Viganego F, O’Donoghue S, Eldadah Z, Shah MH, Rastogi M, Mazel JA, et al. Effect of early diagnosis and treatment with percutaneous lead extraction on survival in patients with cardiac device infections. Am J Cardiol. 2012;109(10):1466–71.

    Article  PubMed  Google Scholar 

  32. Love C, Tomas MB, Tronco GG, Palestro CJ. FDG PET of infection and inflammation. Radiographics. 2005;25(5):1357–68.

    Article  PubMed  Google Scholar 

  33. Jamar F, Buscombe J, Chiti A, Christian PE, Delbeke D, Donohoe KJ, et al. EANM/SNMMI guideline for 18F-FDG use in inflammation and infection. J Nucl Med. 2013;54(4):647–58.

    Article  PubMed  Google Scholar 

  34. Morooka M, Moroi M, Uno K, Ito K, Wu J, Nakagawa T, et al. Long fasting is effective in inhibiting physiological myocardial 18F-FDG uptake and for evaluating active lesions of cardiac sarcoidosis. EJNMMI Res. 2014;4:1.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Boellaard R, Delgado-Bolton R, Oyen WJG, Giammarile F, Tatsch K, Eschner W, et al. FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2015;42(2):328–54.

    Article  CAS  PubMed  Google Scholar 

  36. Boursier C, Duval X, Bourdon A, Imbert L, Mahida B, Chevalier E, et al. ECG-gated cardiac FDG PET acquisitions significantly improve detectability of infective endocarditis. JACC Cardiovasc Imaging. 2020;13(12):2691–3.

    Article  PubMed  Google Scholar 

  37. Mahmood M, Kendi AT, Farid S, Ajmal S, Johnson GB, Baddour LM, et al. Role of 18F-FDG PET/CT in the diagnosis of cardiovascular implantable electronic device infections: a meta-analysis. J Nucl Cardiol. 2019;26(3):958–70.

    Article  PubMed  Google Scholar 

  38. Juneau D, Golfam M, Hazra S, Zuckier LS, Garas S, Redpath C, et al. Positron emission tomography and single-photon emission computed tomography imaging in the diagnosis of cardiac implantable electronic device infection: a systematic review and meta-analysis. Circ Cardiovasc Imaging. 2017;10(4):e005772.

    Article  PubMed  Google Scholar 

  39. JAT S, Barlow G, Chambers JB, Gammage M, Guleri A, Howard P, et al. Guidelines for the diagnosis, prevention and management of implantable cardiac electronic device infection. Report of a joint working party project on behalf of the British Society for Antimicrobial Chemotherapy (BSAC, host organization), British Heart Rhythm Society (BHRS), British cardiovascular society (BCS), British heart valve society (BHVS) and British Society for Echocardiography (BSE). J Antimicrob Chemother. 2015;70(2):325–59.

    Article  Google Scholar 

  40. Duval X, Le Moing V, Tubiana S, Esposito-Farèse M, Ilic-Habensus E, Leclercq F, et al. Impact of systematic whole-body 18F-Fluorodeoxyglucose PET/CT on the management of patients suspected of infective endocarditis: the prospective multicenter TEPvENDO study. Clin Infect Dis. 2020;73(3):393–403. https://doi.org/10.1093/cid/ciaa666/5850646.

    Article  Google Scholar 

  41. Murdoch DR, Corey GR, Hoen B, Miró JM, Fowler VG, Bayer AS, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the international collaboration on endocarditis-prospective cohort study. Arch Intern Med. 2009;169(5):463–73.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Hill EE, Herijgers P, Claus P, Vanderschueren S, Herregods M-C, Peetermans WE. Infective endocarditis: changing epidemiology and predictors of 6-month mortality: a prospective cohort study. Eur Heart J. 2007;28(2):196–203.

    Article  PubMed  Google Scholar 

  43. Habib G, Erba PA, Iung B, Donal E, Cosyns B, Laroche C, et al. Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study. Eur Heart J. 2019;40(39):3222–32.

    Article  PubMed  Google Scholar 

  44. Calais J, Touati A, Grall N, Laouénan C, Benali K, Mahida B, et al. Diagnostic impact of 18F-Fluorodeoxyglucose positron emission tomography/computed tomography and white blood cell SPECT/computed tomography in patients with suspected cardiac implantable electronic device chronic infection. Circ Cardiovasc Imaging. 2019;12(7):e007188.

    Article  PubMed  Google Scholar 

  45. Amraoui S, Tlili G, Sohal M, Berte B, Hindié E, Ritter P, et al. Contribution of PET imaging to the diagnosis of septic embolism in patients with pacing lead endocarditis. JACC Cardiovasc Imaging. 2016;9(3):283–90.

    Article  PubMed  Google Scholar 

  46. Mikail N, Benali K, Ou P, Slama J, Hyafil F, Le Guludec D, et al. Detection of mycotic aneurysms of lower limbs by whole-body (18)F-FDG-PET. JACC Cardiovasc Imaging. 2015;8(7):859–62.

    Article  PubMed  Google Scholar 

  47. Mikail N, Benali K, Mahida B, Vigne J, Hyafil F, Rouzet F, et al. 18F-FDG-PET/CT imaging to diagnose septic emboli and mycotic aneurysms in patients with endocarditis and cardiac device infections. Curr Cardiol Rep. 2018;20(3):14.

    Article  PubMed  Google Scholar 

  48. Calais J, Pasi N, Nguyen V, Hyafil F. Mycotic aneurysm in a pulmonary artery detected with 18F-fluorodeoxyglucose positron emission tomography/computed tomography imaging. Eur Heart J. 2017;38(46):3474.

    PubMed  Google Scholar 

  49. Boursier C, Duval X, Mahida B, Hoen B, Goehringer F, Selton-Suty C, et al. Hypermetabolism of the spleen or bone marrow is an additional albeit indirect sign of infective endocarditis at FDG-PET. J Nucl Cardiol. 2020;28(6):2533–42. https://doi.org/10.1007/s12350-020-02050-2.

    Article  PubMed  Google Scholar 

  50. Jerónimo A, Olmos C, Vilacosta I, Ortega-Candil A, Rodríguez-Rey C, Pérez-Castejón MJ, et al. Accuracy of 18F-FDG PET/CT in patients with the suspicion of cardiac implantable electronic device infections. J Nucl Cardiol. 2020;29(2):594–608.

    Article  PubMed  Google Scholar 

  51. Diemberger I, Bonfiglioli R, Martignani C, Graziosi M, Biffi M, Lorenzetti S, et al. Contribution of PET imaging to mortality risk stratification in candidates to lead extraction for pacemaker or defibrillator infection: a prospective single center study. Eur J Nucl Med Mol Imaging. 2019;46(1):194–205.

    Article  PubMed  Google Scholar 

  52. Signore A, Jamar F, Israel O, Buscombe J, Martin-Comin J, Lazzeri E. Clinical indications, image acquisition and data interpretation for white blood cells and anti-granulocyte monoclonal antibody scintigraphy: an EANM procedural guideline. Eur J Nucl Med Mol Imaging. 2018;45(10):1816–31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Erba PA, Sollini M, Conti U, Bandera F, Tascini C, De Tommasi SM, et al. Radiolabeled WBC scintigraphy in the diagnostic workup of patients with suspected device-related infections. JACC Cardiovasc Imaging. 2013;6(10):1075–86.

    Article  PubMed  Google Scholar 

  54. Holcman K, Małecka B, Rubiś P, Ząbek A, Szot W, Boczar K, et al. The role of 99mTc-HMPAO-labelled white blood cell scintigraphy in the diagnosis of cardiac device-related infective endocarditis. Eur Heart J Cardiovasc Imaging. 2020;21(9):1022–30.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. APHP, Service de Médecine Nucléaire, Hôpital Bichat, Paris, France

    Besma Mahida & François Rouzet

  2. Université Paris Cité, Paris, France

    Besma Mahida & François Rouzet

  3. Inserm U1148, Paris, France

    Besma Mahida & François Rouzet

  4. Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA

    Jérémie Calais

Authors
  1. Besma Mahida
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jérémie Calais
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. François Rouzet
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to François Rouzet .

Editor information

Editors and Affiliations

  1. Montreal Heart Institute, Montréal, QC, Canada

    Matthieu Pelletier-Galarneau

  2. BC Cancer Agency, Vancouver, BC, Canada

    Patrick Martineau

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Mahida, B., Calais, J., Rouzet, F. (2022). Cardiovascular Implantable Electronic Device Infection. In: Pelletier-Galarneau, M., Martineau, P. (eds) FDG-PET/CT and PET/MR in Cardiovascular Diseases. Springer, Cham. https://doi.org/10.1007/978-3-031-09807-9_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-09807-9_14

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-09806-2

  • Online ISBN: 978-3-031-09807-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation